EP3829568
Súlfóprópansýruafleiður til meðhöndlunar á taugahrörnunarröskunum
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
30.7.2019EP published:
6.9.2023EP application number:
19752609.8
EP translation filed:
6.12.2023Grant published:
15.1.2024EPO information:
European Patent Register
Max expiry date:
29.7.2039Expiry date:
29.7.2026Next due date:
31.7.2026
Title in English:
SULFOPROPANOIC ACID DERIVATIVES FOR TREATING NEURODEGENERATIVE DISORDERSLanguage of the patent:
English
Timeline
Today
30.7.2019EP application
6.9.2023EP Publication
6.12.2023Translation submitted
15.1.2024Registration published
29.7.2026Expires
Owner
Name:
Alzheon, Inc.Address:
111 Speen Street Suite 306, Framingham, MA 01701, US
Inventor
Name:
KOCIS, PetrAddress:
Framingham, MA 01701, US
Name:
HEY, JohnAddress:
Framingham, MA 01701, US
Name:
TOLAR, MartinAddress:
Framingham, MA 01701, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201862713056 PDate:
1.8.2018Country:
US
Classification
Categories:
A61K 31/221, A61K 31/222, A61K 31/223, A61K 31/225, A61K 31/255, A61P 25/28, G01N 33/50, G01N 33/52
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 11.7.2024
Expires: 29.7.2025
Payer: G.H. Sigurgeirsson ehf.
Number: 7
Paid: 10.7.2025
Expires: 29.7.2026
Payer: G.H. Sigurgeirsson ehf.